lobbying_activities: 3054976

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3054976	1e754a03-ae98-49e7-84c7-108a5a779517	Q3	PATIENTS RISING NOW	401107039	PATIENTS RISING NOW	2023	third_quarter	PHA	Accelerated Approval. Pharmacy Benefits Managers. S.127 - Pharmacy Benefit Manager Transparency Act of 2023. Medical patents. Alternative Funding Vendors. H.R.2816 - PBM Sunshine and Accountability Act. H.R.2880 - Protecting Patients from PBM Abuses Act. H.R.3839 - Increasing Transparency in Generic Drug Applications Act.	Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE		30000	0	0	2023-10-18T01:10:24-04:00